Skip to content
Conference

Early Detection and Subtype Classification of Lung and Colon Carcinomas Using an Optimized Hybrid Deep Neural Network

Aug 2026 · International Conference on Information Security and Cryptology · pp. 700-705 · 0 citations · 15 references

Abstract

The accurate and early identification of carcinoma subtypes in histopathological images remains a critical challenge in reducing mortality rates associated with lung and colorectal cancers. This paper presents a novel optimized hybrid deep neural network (OHDNN) framework specifically designed for early detection and subtype-level classification of pulmonary and colorectal carcinomas. The proposed architecture synergistically integrates a modified DenseNet201 backbone for hierarchical feature extraction with a cross-attention transformer module for capturing long-range spatial dependencies across histopathological tissue architectures. A multi-objective optimization strategy combining Grey Wolf Optimizer (GWO) and Cuckoo Search (CS) algorithms is introduced for adaptive hyperparameter tuning, including learning rate scheduling, dropout regularization, and layer-wise depth selection. The model is trained and rigorously evaluated on the publicly available LC25000 dataset, comprising 25,000 high-resolution histopathological images across five carcinoma subtypes. Experimental results demonstrate that the proposed OHDNN achieves superior performance with 98.9% accuracy, 98.7% precision, 98.6% recall, and 98.6% F1-score, significantly outperforming conventional CNN architectures, standalone vision transformers, and existing hybrid approaches. The integration of dual optimization mechanisms reduces overfitting by 34% compared to non-optimized baselines while improving convergence speed by 28%. Gradient-weighted class activation mapping (Grad-CAM) analysis confirms that the model attends to pathologically relevant tissue regions, enhancing clinical interpretability. This work establishes the OHDNN as a scalable, interpretable, and highly accurate solution for AI-assisted early carcinoma diagnosis, with significant implications for precision oncology and digital pathology workflows.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.